Park I - Search Results

1

Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer.

Bang YH, Lee CK, Bang K, Kim HD, Kim KP, Jeong JH, Park I, Ryoo BY, Lee DK, Choi HJ, Chung T, Jeon SH, Shin EC, Oum C, Kim S, Lim Y, Park G, Ahn CH, Lee T, Finn RS, Ock CY, Shin J, Yoo C. Bang YH, et al. Among authors: park i, park g. Clin Cancer Res. 2024 Oct 15;30(20):4635-4643. doi: 10.1158/1078-0432.CCR-24-1265. Clin Cancer Res. 2024. PMID: 39150517

2

Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.

Park I, Lee JL, Ryu MH, Kim TW, Sook Lee S, Hyun Park D, Soo Lee S, Wan Seo D, Koo Lee S, Kim MH. Park I, et al. Cancer. 2009 Sep 15;115(18):4148-55. doi: 10.1002/cncr.24472. Cancer. 2009. PMID: 19536892 Free article.

3

Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer.

Park I, Lee JL, Ryu MH, Chang HM, Kim TW, Sym SJ, Lee SS, Jang G, Yoo C, Bae KS, Kang YK. Park I, et al. Cancer Chemother Pharmacol. 2010 Feb;65(3):473-80. doi: 10.1007/s00280-009-1052-3. Epub 2009 Jun 24. Cancer Chemother Pharmacol. 2010. PMID: 19551382 Clinical Trial.

4

Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer.

Jeong JH, Ryu MH, Ryoo BY, Lee SS, Park I, Lee SH, Kim KC, Yook JH, Oh ST, Kim BS, Kang YK. Jeong JH, et al. Among authors: park i. Cancer Chemother Pharmacol. 2012 Oct;70(4):523-9. doi: 10.1007/s00280-012-1935-6. Epub 2012 Aug 5. Cancer Chemother Pharmacol. 2012. PMID: 22864947

5

Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer.

Yoo C, Ryu MH, Na YS, Ryoo BY, Lee CW, Maeng J, Kim SY, Koo DH, Park I, Kang YK. Yoo C, et al. Among authors: park i. Invest New Drugs. 2014 Apr;32(2):271-8. doi: 10.1007/s10637-013-9983-2. Epub 2013 May 28. Invest New Drugs. 2014. PMID: 23712440 Clinical Trial.

6

Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer.

Park JH, Ryu MH, Kim HJ, Ryoo BY, Yoo C, Park I, Park YS, Oh ST, Yook JH, Kim BS, Kang YK. Park JH, et al. Among authors: park ys, park i. Gastric Cancer. 2016 Jan;19(1):226-33. doi: 10.1007/s10120-015-0464-5. Epub 2015 Jan 23. Gastric Cancer. 2016. PMID: 25614467

7

Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.

Yoo C, Ryu MH, Jo J, Park I, Ryoo BY, Kang YK. Yoo C, et al. Among authors: park i. Cancer Res Treat. 2016 Apr;48(2):546-52. doi: 10.4143/crt.2015.015. Epub 2015 Jun 22. Cancer Res Treat. 2016. PMID: 26130666 Free PMC article.

8

Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.

Kim HD, Im HS, Kim JH, Jeong H, Yoon SK, Park I, Lee JL. Kim HD, et al. Among authors: park i. Cancer Res Treat. 2021 Oct;53(4):1166-1173. doi: 10.4143/crt.2021.091. Epub 2021 Mar 4. Cancer Res Treat. 2021. PMID: 33677847 Free PMC article.

9

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.

Yoon S, Kim M, Hong YS, Kim HS, Kim ST, Kim J, Yun H, Yoo C, Ahn HK, Kim HS, Lee IH, Kim IH, Park I, Jeong JH, Cheon J, Kim JW, Yun J, Lim SM, Cha Y, Jang SJ, Zang DY, Kim TW, Kang JH, Kim JH. Yoon S, et al. Among authors: park i. Cancer Res Treat. 2022 Jan;54(1):1-9. doi: 10.4143/crt.2021.1115. Epub 2021 Dec 13. Cancer Res Treat. 2022. PMID: 34902959 Free PMC article.

10

ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.

Yoon S, Kim M, Hong YS, Kim HS, Kim ST, Kim J, Yun H, Yoo C, Ahn HK, Kim HS, Lee IH, Kim IH, Park I, Jeong JH, Cheon J, Kim JW, Yun J, Lim SM, Cha Y, Jang SJ, Zang DY, Kim TW, Kang JH, Kim JH. Yoon S, et al. Among authors: park i. Cancer Res Treat. 2023 Jul;55(3):1061. doi: 10.4143/crt.2021.1115.E. Epub 2023 Apr 21. Cancer Res Treat. 2023. PMID: 37114287 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,098 results

Search Page

Filters